1.
Lapatinib in Combination with Bortezomib Inhibits Breast Cancer Cells Growth and the Activity of Bortezomib to Lapatinib-resistant Breast Cancer Cell
拉帕替尼联合硼替佐米抑制乳腺癌细胞生长及硼替佐米对拉帕替尼耐药细胞的活性的研究
2.
The Clinical Observation of Bortezomib Used in Relapsed or Refractory Hematologic Malignancy;
硼替佐米治疗难治性血液恶性肿瘤临床观察
3.
The Curative Effect Observation of Bortezomib Combined with Dexamethasone to Treat Multiple Myeloma;
硼替佐米治疗多发性骨髓瘤的疗效观察
4.
Effect of Bortezomib on Proliferation and Apoptosis of Human Lymphoma Raji Cells
硼替佐米对淋巴瘤Raji细胞增殖及凋亡的影响
5.
A Clinical Observation of Bortezomib to Treat Multiple Myeloma of 18 Patients
硼替佐米治疗18例多发性骨髓瘤的临床观察
6.
Determination of Bortezomib in Its Crude Drug by RP-HPLC
RP-HPLC法测定硼替佐米原料药中主药的含量
7.
Effects of bortezomib plus VAD in treatment of multiple myeloma
硼替佐米联合VAD方案治疗多发性骨髓瘤
8.
Apoptosis of Burkitt's Lymphoma Raji Cell Line Induced by Bortezomib
硼替佐米诱导Burkitt淋巴瘤Raji细胞凋亡的研究
9.
Progress of Bortezomib in the Treatmen of Myeloma Bone Disease
硼替佐米治疗骨髓瘤性骨病的研究进展
10.
Bortezomib plus chemotherapy for the treatment of newly diagnosed patients with multiple myeloma
硼替佐米治疗新诊断多发性骨髓瘤的临床观察
11.
Effects of bortezomib on the proliferation,apoptosis and adhesive ability of HCT8 cells
硼替佐米对HCT8细胞增殖、凋亡及黏附能力的影响
12.
Treatment of Newly Diagnosed Multiple Myeloma Based on Bortezomib Plus Dexamethasone;
硼替佐米联合地塞米松治疗初发的多发性骨髓瘤的疗效评价
13.
Bortezomib Combined with Dexamethasone to Treat Multiple Myeloma
硼替佐米联合地塞米松治疗多发性骨髓瘤的疗效观察
14.
The Curative Effect Observation of Bortezomib Combination with Dexamethasone in 35 Patients with Multiple Myeloma
硼替佐米联合大剂量地塞米松治疗多发性骨髓瘤35例疗效观察
15.
Clinical experience and prognostic factors with bortezomib combined regimen in 40 patients with multiple myeloma
硼替佐米联合地塞米松治疗多发性骨髓瘤疗效及影响因素分析
16.
Bortezomib in combination with dexamethasone for the treatment of stage-Ⅲ multiple myeloma
硼替佐米联合地塞米松治疗Ⅲ期多发性骨髓瘤临床观察
17.
Bortezomib combined with dexamethasone for newly diagnosed multiple myeloma
硼替佐米联合地塞米松治疗初诊多发性骨髓瘤的初步观察
18.
Clinical Study on Bortezomib and Thalidomide in the Treatment of Multiple Myeloma;
硼替佐米和沙利度胺治疗多发性骨髓瘤的临床研究